BioHarvest Sciences Inc. - Common Stock (BHST)

4.0600
+0.0500 (1.25%)
NASDAQ· Last Trade: May 14th, 1:08 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close4.010
Open3.950
Bid4.050
Ask4.280
Day's Range3.922 - 4.235
52 Week Range3.570 - 12.80
Volume14,270
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume34,241

Chart

About BioHarvest Sciences Inc. - Common Stock (BHST)

BioHarvest Sciences Inc. is a biotechnology company focused on the innovative development of natural and sustainable solutions for various industries, including health and wellness, cosmetics, and agriculture. The company specializes in harnessing advanced cellular agriculture technology to cultivate plant-based ingredients with enhanced nutritional and therapeutic properties. By utilizing proprietary methods to grow and produce biomass from living cells, BioHarvest aims to provide high-quality products that are environmentally friendly and offer significant health benefits, thus contributing to healthier lifestyles and more sustainable production practices. Read More

News & Press Releases

BioHarvest Sciences Q1 Earnings Call Highlightsmarketbeat.com
BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer VINIA products business and its contract development and manufacturing organization, or CDMO, plat
Via MarketBeat · May 14, 2026
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron...
Via Newsfile · May 14, 2026
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · May 13, 2026
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production...
Via Newsfile · May 13, 2026
Earnings Scheduled For November 13, 2025benzinga.com
Via Benzinga · November 13, 2025
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows...
Via Newsfile · May 12, 2026
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · April 30, 2026
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role...
Via Newsfile · April 29, 2026
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
FY2025 Revenues were $34.5 million, up 37% vs previous year.The VINIA brand has achieved the No.1 resveratrol polyphenol...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the...
Via Newsfile · March 26, 2026
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · March 17, 2026
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 5, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the...
Via Newsfile · March 5, 2026
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a...
Via Newsfile · March 3, 2026
BioHarvest Sciences Issues Year End Shareholder Letter
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 7, 2026) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0)...
Via Newsfile · January 7, 2026
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · December 18, 2025
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the $13 Billion U.S. Electrolyte MarketVancouver, British Columbia and Rehovot,...
Via Newsfile · December 3, 2025
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
Company Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via ...
Via Newsfile · November 13, 2025
BioHarvest Sciences Inc. - Common Stock Earnings Previewbenzinga.com
Via Benzinga · November 12, 2025
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 12, 2025
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 10, 2025
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 7, 2025
BioHarvest Announces Proposed Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 6, 2025
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 4, 2025
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
Partnership with "Saffron Tech" to Advance Production of One of the World's Most Valuable BotanicalsManagement Concurrently Shares Third Quarter 2025...
Via Newsfile · October 30, 2025